Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study evaluated the effectiveness of two automated systems for assessing care quality in type 2 diabetes management, finding high completeness and correctness in system comments.
Orem’s Self-Care Model-based program improved glycemic control and psychosocial self-care in Palestinian children with T1DM.
This study evaluated the efficacy and safety of a triple fixed-dose combination of sitagliptin, metformin, and glimepiride in Indian patients with uncontrolled Type 2 diabetes, finding significant reductions in HbA1c levels.
Dapagliflozin demonstrated significant improvements in key health markers in participants with Type 2 Diabetes Mellitus.
Topical ozonated olive oil significantly improved wound healing and quality of life in diabetic foot ulcer patients compared to standard care.
This study evaluated the impact of receptive music therapy combined with usual nursing care on cognitive performance and quality of life in elderly patients with type 2 diabetes.
The study evaluated a Therapeutic Yoga Module (TYM) aimed at improving glycemic control in individuals with impaired fasting glucose, showing significant reductions in fasting blood glucose and HbA1c levels.
This study evaluated the efficacy and safety of a fixed-dose combination of dapagliflozin and pioglitazone in patients with type 2 diabetes inadequately controlled on metformin. The findings suggested that while both treatments reduced HbA1c, the fixed-dose combination had a higher rate of adverse events.
This study investigated the impact of fatty fish consumption on plasma CMPF concentration and glucose metabolism in individuals with impaired glucose metabolism. Results indicated that increased fish consumption did not correlate with impaired glucose metabolism.
This study explored a video game intervention aimed at enhancing diabetes-related numeracy but found no long-term benefits.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
